068760.KQ KOE
Celltrion Pharm, Inc.
1W: -1.7%
1M: -7.6%
3M: -7.0%
YTD: -45.4%
1Y: -27.4%
3Y: -52.5%
5Y: -70.9%
₩38,400.00 ($28.54)
-1250.00 (-3.15%)
Weekly Expected Move ±3.4%
₩35808
₩37104
₩38400
₩39696
₩40992
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩1.70T ($1.3B)
52W Range37000-78300
Volume99,025
Avg Volume94,064
Beta0.96
Dividend₩200.00
Analyst Ratings
No analyst coverage
Company Info
CEOYoo Young-Ho
Employees888
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2006-02-03
Websitecelltrionph.com
82, 2sandan-ro
Cheongju, NC
KR
Cheongju, NC
KR
82 4 3717 7000
About Celltrion Pharm, Inc.
Celltrion Pharm Inc. operates as a South Korean pharmaceutical firm, specializing in the creation and distribution of biosimilar medications and over-the-counter (OTC) drugs. Its extensive product portfolio spans a multitude of therapeutic categories, encompassing treatments for conditions related to liver health, inflammation, allergies, respiratory and cardiovascular systems, digestion, hormonal and metabolic disorders, infectious diseases, immune responses, oncology, and general nutrition. The company supplies its pharmaceutical offerings to a diverse client base, including university hospitals and local pharmacies. Established in 1976, Celltrion Pharm Inc. is based in Cheongju, South Korea.
Latest News
No recent news
Recent Insider Trades
No insider trades found